Evidence map›Paper›PMID 39060693›Full record

ArticleAnnals of surgical oncology2024

Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.

Alexandra E Hernandez, Peter A Borowsky, Maya Lubarsky, Carin Carroll, Seraphina Choi, Susan Kesmodel, Michael Antoni, Neha Goel

Erratum issuedAbstract read
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Alexandra E HernandezDivision of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Peter A BorowskyDivision of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Maya LubarskyUniversity of Miami Miller School of Medicine, Miami, FL, USA.
Carin CarrollUniversity of Miami Miller School of Medicine, Miami, FL, USA.
Seraphina ChoiUniversity of Miami Miller School of Medicine, Miami, FL, USA.
Susan KesmodelDivision of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Michael AntoniDepartment of Human Genetics, University of Miami Miller School of Medicine, Miami, FL, USA.
Neha GoelDivision of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. neha.goel@med.miami.edu.

Funding

Tumor Biology Research ProgramP30CA240139 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI George S. Grills · 2019 to 2026
$24.1M
UM Calabresi Clinical Oncology Research Career Development AwardK12CA226330 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Alan Pollack · 2018 to 2026
$5.1M
Culturally Adapted Cognitive Behavioral Stress and Self-Management (C-CBSM) Intervention for PCR01CA206456 · NCI · UNIVERSITY OF MIAMI CORAL GABLES · PI ANTONI, MICHAEL HOWARD, PENEDO, FRANK J · 2016 to 2021
$4.2M
Technology Facilitated Behavioral Intervention for Depression among Diverse Patients in Ambulatory OncologyR37CA255875 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BETINA YANEZ · 2021 to 2026
$4.0M
Training to Reduce Burden across the Cancer Control Continuum (TRACC)T32CA251064 · NCI · UNIVERSITY OF MIAMI CORAL GABLES · PI ERIN N KOBETZ, Frank J Penedo · 2020 to 2026
$3.2M
Research Training Program in Surgical OncologyT32CA211034 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MERCHANT, NIPUN B. · 2016 to 2025
$2.7M
Avanzando Caminos (Leading Pathways): The Hispanic/Latino Cancer Survivorship Cohort Study.”UG3CA260317 · NCI · UNIVERSITY OF MIAMI CORAL GABLES · PI PENEDO, FRANK J, RAMIREZ, AMELIE G · 2021 to 2022
$2.0M
eHealth Supported Mindfulness-based Music Therapy Intervention (eMBMT) in Hemopoietic Stem Cell Transplant PatientsR61CA263335 · NCI · UNIVERSITY OF MIAMI CORAL GABLES · PI LESIUK, TERESA LYNN, PENEDO, FRANK J · 2022 to 2023
$866k
CLC NIH HHS 1P30CA240139-01CLC NIH HHS 5P30 240139-02Foundation for the National Institutes of Health 5T32CA251064-04Foundation for the National Institutes of Health K12CA226330Foundation for the National Institutes of Health R01CA206456Foundation for the National Institutes of Health T32CA211034NCI NIH HHS K12 CA226330NCI NIH HHS P30 CA240139NCI NIH HHS R01 CA206456NCI NIH HHS R37 CA255875NCI NIH HHS R61 CA263335NCI NIH HHS T32 CA211034NCI NIH HHS T32 CA251064NCI NIH HHS UG3 CA260317Patient-Centered Outcomes Research Institute AD-2020C3-21171
6 · The paper itself

Abstract

backgroundDespite higher breast cancer screening rates, black women still are more likely to have late-stage disease diagnosed. This disparity is influenced in part by structural and interpersonal racism. This prospective study sought to determine how interpersonal factors, including perceived discrimination, influence screening and stage of disease at diagnosis.

methodsA prospective cohort study analyzed adult women with stages I to IV breast cancer from the Miami Breast Cancer Disparities Study. Perceived discrimination and mistrust of providers were assessed using previously validated questionnaires. Multivariable logistic regression was used to evaluate the odds of screening mammography utilization and late-stage breast cancer at diagnosis.

resultsThe study enrolled 342 patients (54.4 % Hispanic, 15.8 % white, and 17.3 % black). Multivariate regression, after control for both individual- and neighborhood-level factors, showed that a higher level of perceived discrimination was associated with greater odds of late-stage disease (adjusted odds ratio [aOR], 1.06; range, 1.01-1.12); p = 0.022) and lower odds of screening mammography (aOR, 0.96; range, 0.92-0.99; p = 0.046). A higher level of perceived discrimination also was negatively correlated with multiple measures of provider trust. DISCUSSION: This study identified that high perceived level of discrimination is associated with decreased odds of ever having a screening mammogram and increased odds of late-stage disease. Efforts are needed to reach women who experience perceived discrimination and to improve the patient-provider trust relationship because these may be modifiable risk factors for barriers to screening and late-stage disease presentation, which ultimately have an impact on breast cancer survival.

Indexed as

Breast NeoplasmsEarly Detection of CancerMammographyNeoplasm StagingAdultAgedBlack or African AmericanFemaleFollow-Up StudiesHealthcare DisparitiesHispanic or LatinoHumansMiddle AgedPerceptionPrognosisProspective StudiesBreast cancerDisparitiesPerceived discriminationScreening mammographyStage at diagnosisStructural racism

Identifiers

PMID39060693
PMCPMC11467043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.